Significant Changes in Anti-Epilepsy Treatment Options

by Bidita Debnath on  December 5, 2012 at 12:29 PM Research News
RSS Email Print This Page Comment
The best hormonal treatment for infantile spasms (IS) that may lead to changes in prescribing practices for hormone therapy.
 Significant Changes in Anti-Epilepsy Treatment Options
Significant Changes in Anti-Epilepsy Treatment Options

A pilot study to determine this is being presented for the first time at the American Epilepsy Society's 66th Annual Meeting in San Diego California (Abstract #1.247).

In a study of 30 infants, researchers from the division of Pediatric Neurology of Mattel Children's Hospital at UCLA in Los Angeles found very high dose prednisolone to be a reasonable alternative to adrenocorticotropic hormone treatment (ACTH) for children with infantile spasms . Using a standardized protocol in which ACTH is reserved for infants who do not respond to prednisolone, they yielded a favorable overall response rate of 77%, and were able to successfully forego ACTH therapy in 18 patients, thus avoiding more than 1000 intramuscular injections and achieving more than 2 million dollars in short-term cost savings. The results indicate that further research is warranted to determine whether high dose prednisolone is truly equivalent is ACTH, as 5 infants in this study responded to ACTH after failing prednisolone.

"In the absence of a definitive clinical trial, I encourage practitioners to use the treatment protocol set forth in our study to mitigate the risks and cost of traditional ACTH therapy. However, I do not advocate that ACTH therapy be completely abandoned. A head-to-head trial of high-dose prednisolone versus ACTH is required to resolve the uncertainly that remains." said Dr. Shaun Hussain of the Division of Neurology, Mattel Children's Hospital at UCLA, the lead author of the study.
The study was presented at a session of pediatric highlights at the AES Annual Meeting.

Source: Newswise

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.


Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive